PRESS RELEASE
5 March 2026

Maples Group Advises Hansoh Pharmaceutical On Vienna MTF Listing Of Convertible Bonds

MG
Maples Group

Contributor

The Maples Group is a leading service provider offering clients a comprehensive range of legal services on the laws of the British Virgin Islands, the Cayman Islands, Ireland, Jersey and Luxembourg, and is an independent provider of fiduciary, fund services, regulatory and compliance, and entity formation and management services.
Maples and Calder, the Maples Group’s law firm, is pleased to announce it has advised Hansoh Pharmaceutical Group Company Limited (“Hansoh”) on its issuance of HK$4,680 million zero-coupon...
Cayman Islands

Maples and Calder, the Maples Group's law firm, is pleased to announce it has advised Hansoh Pharmaceutical Group Company Limited ("Hansoh") on its issuance of HK$4,680 million zero-coupon convertible bonds due 2033 (the "Bonds") and the listing of the Bonds on the Vienna MTF (Multilateral Trading Facility) operated by the Vienna Stock Exchange. The listing was completed on 4 February 2026.

Hansoh is a leading pharmaceutical company engaged in the research, development, production and sale of a broad portfolio of pharmaceutical products.

A team based in the firm's Hong Kong office acted as Cayman Islands counsel to Hansoh. The team was led by Matt Roberts, Partner and Head of Corporate, Asia, with assistance from Legal Managers, Kelvan Cheung and Clare Tsang.

Cleary Gottlieb Steen & Hamilton (Hong Kong) acted as English and Hong Kong legal counsel to Hansoh. Linklaters acted as English and Hong Kong legal counsel to the managers, Citigroup Global Markets Limited and Morgan Stanley Asia Limited.

Contributor

The Maples Group is a leading service provider offering clients a comprehensive range of legal services on the laws of the British Virgin Islands, the Cayman Islands, Ireland, Jersey and Luxembourg, and is an independent provider of fiduciary, fund services, regulatory and compliance, and entity formation and management services.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More